Wipro partners with Transcell Oncologics to transform vaccine safety assessment strategies

06 May 2021 Evaluate

Wipro has entered into partnership with Transcell Oncologics to transform vaccine safety assessment using artificial intelligence. This alliance combines Transcell’s innovative stem cell technology with the advanced artificial intelligence capabilities of Wipro HOLMES, enabling customers to improve the safety of global vaccine immunization programs.

This alliance will add a new portfolio to Wipro HOLMES life sciences capability, which has impactful offerings that apply AI for drug repurposing and Messenger Ribonucleic Acid (mRNA) based platform for biodefense.

Wipro is a leading global information technology, consulting and business process services company.

Wipro Share Price

444.65 0.35 (0.08%)
19-Apr-2024 11:16 View Price Chart
Peers
Company Name CMP
TCS 3821.30
Infosys 1404.70
HCL Tech. 1445.85
Wipro 444.65
Tech Mahindra 1175.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.